Improvement in fatty acid utilization in relation to a change in left ventricular hypertrophy in spontaneously hypertensive rats

Japanese Circulation Journal

Volumn 64, Issue 2, 2000, Pages 177-120

  Ono, Tomohide ^a   Kohya, Tetsuro ^a   Tsukamoto, Eriko ^a   Mochizuki, Takafumi ^a   Itoh, Kazuo ^a   Itoh, Yoshinori ^a   Tomita, Fumishi ^a   Tamaki, Nagara ^a   Kitabatake, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; BMIPP; Myocardial hypertrophy; Regression of hypertrophy; Thallium

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 125; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; CONTRAST MEDIUM; FATTY ACID; HYDRALAZINE; THALLIUM 201; UNCLASSIFIED DRUG; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FATTY ACID METABOLISM; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE PERFUSION; HEART WEIGHT; HYPERTENSION; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ANIMAL; BLOOD PRESSURE; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPTOPRIL; FATTY ACIDS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; RATS; RATS, INBRED SHR;

EID: 0034131914     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.64.117     Document Type: Article

References (27)

1. Fujihayashi Y, Yonekura Y, Taemura Y, Wada K, Matsumoto K, Tamaki N. et al: Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methylpenta-decanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31: 1818-1822
2. 125I]-(p-iodophenyl)-3-(R.S) methylpentadecanoic acid (BMIPP). and correlation to ATP concentration, II. Nucl Med Biol 1993; 20: 163-166
3. Tamaki N, Kawamoto M: The use of iodinated free fatty acids for assessing fatty acid metabolism. J Nucl Cardiol 1994; 1: 72-78
4. Tamaki N, Fujihayashi Y, Magata Y, Yonekura Y, Konishi J: Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT. J Nucl Curdiol 1999; 2: 256-266
5. Yamamichi Y, Kusuoka H, Morishita K, Shirakami Y, Kurami M, Okano K, et al: Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995; 36: 1043-1050
6. Mochizuki T, Tsukamoto E, Ono T, Itoh K, Kanegae K, Katoh C, et al: Sequential changes of BMIPP uptake in spontaneously hypertensive rat model. Ann Nucl Med 1997; 11: 299-306
7. Yonekura Y, Brill B, Som P: Regional myocardial substrate uptake in hypertensive rats: A quantitative autoradiographic measurement. Science 1985; 227: 1494-1496
8. Yamamoto K, Som P, Brill AB, Yonekura Y, Srivastava SC, Meinken CE, et al: Dual tracer autoradiographic study of beta-methyl-(1-14C) heptadecanoic acid and 15-p-(131I)-iodophenyl-beta-methylpentadecanoic acid in normotensive and hypertensive rats. J Nucl Med 1986; 27: 1178-1183
9. Sago M, Nishimura T: Serial assessment of myocardial thallium perfusion and fatty acid utilization in spontaneously hypertensive rats: assessment by autoradiography and pin-hole imaging. Kakuigaku (Jpn J Nucl Med) 1989; 26: 855-863
10. Kagaya Y, Kanno Y, Takeyama D, Ishide N, Maruyama Y, Takahashi T, et al: Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats: A quantitative autoradiographic study. Circulation 1990; 81: 1353-1361
11. Tsoporis J, Leenen FH: Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. Hypertension 1988; 11: 376-386
12. Tanaka H, Obata H, Haneda T: Effects of regression of left ventricular hypertrophy following atenolol or bunazosin therapy on ischemic cardiac function and myocardial metabolism in spontaneously hypertensive rats. Jpn Circ J 1991; 55: 1233-1245
13. Leenen FH, Smith DL, Farkas RM: Vasodilators and regression of left ventricular hypertrophy: Hydralazine versus prazosin in hypertensive humans. Am J Med 1987; 82: 969-978
14. Sen S, Tarazi RC, Bumpus FM: Effect of converting enzyme inhibitor (SQ14, 2-25) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension 1980; 2: 169-176
15. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E: Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci USA 1982; 79: 3310-3314
16. Kohya T, Yokoshiki H, Tohse N, Kanno M, Nakaya H, Saito H, et al: Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias: benefical effect of angiotensin II blockade. Circ Res 1995; 76: 892-899
17. Sen S, Tarazi RC, Khairallah PA, Bumpus FM: Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 1974; 35: 775-781
18. Guide for the care and use of laboratory animals, revised 1985. N1H publication no. 86-23
19. 123I-β-methyl-iodophenyl pentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (Occlusion and reperfusion model). Eur J Nucl Med 1989; 15: 341-345
20. Haneda T, Ichihara K, Abiko Y, Onodera S: Functional and metabolic responses to ischemia in the perfused heart isolated from normotensive and spontaneously hypertensive rats. Jpn Circ J 1986; 50: 607-613
21. Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD: Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 1994; 267: H742-H750
22. 31P NMR spectroscopic study. Circulation 1995; 92: 1274-1283
23. Taegtmeyer H, Overturf ML: Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension 1988; 11: 416-426
24. Foster KA, O'Rourke B, Reibel DK: Altered camitine metabolism in spontaneously hypertensive rats. Am J Physiol 1985; 249: E183-E186
25. Fujii S, Kawaguchi H, Okamoto H, Saito H, Togashi H, Yasuda H: Fatty acid binding protein of cardiac muscle in spontaneously hypertensive rats: effect of hypertrophy and its regression. J Mol Cell Cardiol 1988; 20: 779-787
26. Brilla-CG, Janicki-JS, Weber-KT: Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991; 83: 1771-1779
27. Brooks WW, Bing OH, Robinson KG, Slawsky MT, Chaletsky DM, Conrad CH: Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat. Circulation 1997; 96: 4002-4010